York Charles N II

Number of records: 39
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
Yesterday 6:15 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 16-May-24Option Sale 2,675$16.08$43,010.50(1%)
227.54K to 224.87K
Yesterday 6:15 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 15-May-24Option Exercise 10,250----5%
217.29K to 227.54K
03-May-24 6:44 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 03-May-24Sale (Planned) 8,078$17.85$144,214.00(4%)
225.37K to 217.29K
03-May-24 6:44 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 02-May-24Sale (Planned) 200$17.90$3,579.10(< 1%)
225.57K to 225.37K
03-May-24 6:44 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 01-May-24Private Sale (Planned) 52,183$17.89$933,397.00(19%)
277.75K to 225.57K
20-Feb-24 6:36 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 16-Feb-24Option Sale 2,666$15.25$40,651.40(< 1%)
280.42K to 277.75K
20-Feb-24 6:36 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 15-Feb-24Option Exercise 10,250----4%
270.17K to 280.42K
17-Nov-23 6:33 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 16-Nov-23Option Sale 956$11.69$11,175.60(< 1%)
271.13K to 270.17K
17-Nov-23 6:33 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 15-Nov-23Option Exercise 3,625----1%
267.5K to 271.13K
17-Aug-23 7:02 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 17-Aug-23Option Sale 922$13.86$12,778.90(< 1%)
268.42K to 267.5K
17-Aug-23 7:02 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 15-Aug-23Option Exercise 3,625----1%
264.8K to 268.42K
17-May-23 6:36 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 16-May-23Option Sale 955$13.12$12,531.80(< 1%)
265.75K to 264.8K
17-May-23 6:36 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 15-May-23Option Exercise 3,625----1%
262.13K to 265.75K
21-Feb-23 5:01 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 17-Feb-23Private Sale (Planned) 9,377$20.03$187,790.00(3%)
271.5K to 262.13K
17-Feb-23 5:35 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 16-Feb-23Option Sale 930$19.57$18,202.90(< 1%)
272.44K to 271.5K
17-Feb-23 5:35 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 15-Feb-23Option Exercise 3,625----1%
268.81K to 272.44K
23-Jan-23 6:00 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 20-Jan-23Private Sale (Planned) 10,000$22.75$227,523.00(4%)
278.81K to 268.81K
22-Dec-22 5:43 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 20-Dec-22Private Sale (Planned) 10,000$20.07$200,650.00(3%)
286.5K to 276.5K
22-Nov-22 6:46 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 21-Nov-22Private Sale (Planned) 10,000$20.76$207,570.00(3%)
296.5K to 286.5K
17-Nov-22 5:49 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 16-Nov-22Option Sale 430$21.46$9,227.71(< 1%)
296.93K to 296.5K
17-Nov-22 5:49 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 15-Nov-22Option Exercise 1,375----< 1%
294.4K to 295.78K
03-Nov-22 5:49 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 01-Nov-22Private Sale (Planned) 10,000$20.03$200,313.00(3%)
304.4K to 294.4K
05-Oct-22 4:36 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 03-Oct-22Private Sale (Planned) 10,000$20.05$200,473.00(3%)
314.4K to 304.4K
06-Sep-22 7:54 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 01-Sep-22Private Sale (Planned) 10,000$23.25$232,484.00(3%)
324.4K to 314.4K
17-Aug-22 7:23 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 16-Aug-22Option Sale 1,089$24.31$26,473.60(< 1%)
325.49K to 324.4K
17-Aug-22 7:23 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 15-Aug-22Option Exercise 4,125----1%
321.37K to 325.49K
05-Aug-22 5:20 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 04-Aug-22Private Sale (Planned) 10,000$20.05$200,541.00(3%)
331.37K to 321.37K
20-Jul-22 6:18 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 18-Jul-22Private Sale (Planned) 2,500$20.00$50,000.00(< 1%)
333.87K to 331.37K
12-Jul-22 7:31 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 08-Jul-22Private Sale (Planned) 1,416$20.00$28,320.00(< 1%)
335.28K to 333.87K
06-Jul-22 9:00 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 05-Jul-22Sale (Planned) 800$20.00$16,000.00(< 1%)
336.08K to 335.28K
06-Jul-22 9:00 PM
View: 
Day One Biopharmaceuticals,... (DAWN) 01-Jul-22Private Sale (Planned) 1,479$20.00$29,580.00(< 1%)
337.56K to 336.08K
05-Dec-17 9:07 PM
View: 
Spyre Therapeutics, Inc. (SYRE) 05-Dec-17Market Purchase 10,241$4.76$48,700.1042%
24.55K to 34.79K
75%
05-Dec-17 9:07 PM
View: 
Spyre Therapeutics, Inc. (SYRE) 04-Dec-17Market Purchase 3,259$4.97$16,196.9015%
21.29K to 24.55K
68%
05-Dec-17 9:07 PM
View: 
Spyre Therapeutics, Inc. (SYRE) 01-Dec-17Market Purchase 6,500$4.59$29,855.2044%
14.79K to 21.29K
82%
05-Dec-17 9:07 PM
View: 
Spyre Therapeutics, Inc. (SYRE) 15-Aug-17Private Purchase 1,959$2.52$4,928.8415%
12.83K to 14.79K
05-Dec-17 9:07 PM
View: 
Spyre Therapeutics, Inc. (SYRE) 15-Feb-17Private Purchase 2,000$4.28$8,568.0018%
10.83K to 12.83K
05-Dec-17 9:07 PM
View: 
Spyre Therapeutics, Inc. (SYRE) 15-Aug-16Private Purchase 2,000$3.99$7,974.0023%
8.83K to 10.83K
12-Apr-16 5:15 PM
View: 
Spyre Therapeutics, Inc. (SYRE) 12-Apr-16Conversion 1,324----18%
7.5K to 8.83K
12-Apr-16 5:15 PM
View: 
Spyre Therapeutics, Inc. (SYRE) 12-Apr-16Conversion 11,560----131%
8.83K to 20.39K